Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Exp Gerontol. 2015 Nov 27;73:86–94. doi: 10.1016/j.exger.2015.11.017

Figure 3.

Figure 3

Acute mineralocorticoid receptor antagonism with eplerenone decreased the amount of activated eNOS as measured by the ratio of phosphorylated eNOS at Ser1177 (P-eNOSSer1177) to total eNOS. *P=0.02 vs. placebo.